Filing Details
- Accession Number:
- 0001534969-22-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-15 17:58:27
- Reporting Period:
- 2022-03-14
- Accepted Time:
- 2022-03-15 17:58:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1534969 | Sera Prognostics Inc. | SERA | Services-Medical Laboratories (8071) | 261911522 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1870674 | J. John Boniface | C/O Sera Prognostics, Inc. 2749 East Parleys Way, Suite 200 Salt Lake City UT 84109 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2022-03-14 | 2,725 | $3.94 | 98,285 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2021.